155 related articles for article (PubMed ID: 1707117)
1. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy.
Boden WE
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S55-60. PubMed ID: 1707117
[TBL] [Abstract][Full Text] [Related]
2. Strategies for managing the patient with acute non-Q-wave myocardial infarction.
Boden WE
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III33-40. PubMed ID: 2575020
[TBL] [Abstract][Full Text] [Related]
3. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
[TBL] [Abstract][Full Text] [Related]
4. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction.
Gibson RS
Circulation; 1989 Dec; 80(6 Suppl):IV107-19. PubMed ID: 2574639
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists in myocardial infarction.
Zannad F; Sadoul N
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
[TBL] [Abstract][Full Text] [Related]
6. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
Cambou JP; Simon T; Mulak G; Bataille V; Danchin N
Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635
[TBL] [Abstract][Full Text] [Related]
7. Review of calcium antagonist trials in acute myocardial infarction.
Roberts R
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
[TBL] [Abstract][Full Text] [Related]
8. Therapy for acute myocardial infarction.
Rich MW
Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
[TBL] [Abstract][Full Text] [Related]
9. Calcium-channel blockers as adjuvant therapy postthrombolysis.
Boden WE
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S102-6. PubMed ID: 1724997
[TBL] [Abstract][Full Text] [Related]
10. Q wave versus non-Q wave myocardial infarction: morbidity and mortality patterns after cardiac rehabilitation.
Desmarais PL; Cox CL
J Cardiovasc Nurs; 2006; 21(2):118-22. PubMed ID: 16601528
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers in myocardial infarction.
Skolnick AE; Frishman WH
Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
[TBL] [Abstract][Full Text] [Related]
12. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
[TBL] [Abstract][Full Text] [Related]
13. Non-Q-wave myocardial infarction. An incomplete cardiac event requiring an aggressive approach.
Nixon JV
Postgrad Med; 1994 Apr; 95(5):211-4, 216-8, 221-3. PubMed ID: 8153044
[TBL] [Abstract][Full Text] [Related]
14. Negative and positive predictive values of routine exercise testing in stable, medically-treated patients several years following a Q-wave myocardial infarction.
Casella G; Pavesi PC; Niro MD; Bracchetti D
Ital Heart J; 2001 Apr; 2(4):271-9. PubMed ID: 11374496
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
Roberts R
Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
[TBL] [Abstract][Full Text] [Related]
16. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
Just H; Frey M
Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction.
Gomez JF; Zareba W; Moss AJ; McNitt S; Hall WJ
Am J Cardiol; 2007 Mar; 99(5):642-6. PubMed ID: 17317364
[TBL] [Abstract][Full Text] [Related]
18. Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trial.
Heggunje PS; Wade MJ; O'Rourke RA; Kleiger RE; Deedwania PC; Lavori PW; Boden WE;
Eur Heart J; 2000 Dec; 21(24):2014-25. PubMed ID: 11102252
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention after myocardial infarction: in favor of beta-blockers.
Lévy S
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
